Cargando…

Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies

BACKGROUND: Convalescent plasma is one of the treatment options for COVID-19 which is currently being investigated in many clinical trials. Understanding of donor and product characteristics is important for optimization of convalescent plasma. METHODS: Patients who had recovered from COVID-19 were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Körper, Sixten, Jahrsdörfer, Bernd, Corman, Victor M., Pilch, Jan, Wuchter, Patrick, Blasczyk, Rainer, Müller, Rebecca, Tonn, Torsten, Bakchoul, Tamam, Schäfer, Richard, Juhl, David, Schwarz, Tatjana, Gödecke, Nina, Burkhardt, Thomas, Schmidt, Michael, Appl, Thomas, Eichler, Hermann, Klüter, Harald, Drosten, Christian, Seifried, Erhard, Schrezenmeier, Hubert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger GmbH 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216018/ https://www.ncbi.nlm.nih.gov/pubmed/34177417 http://dx.doi.org/10.1159/000515610

Ejemplares similares

SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays
por: Seidel, Alina, et al.
Publicado: (2023)

BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Elderly Convalescents
por: Jahrsdörfer, Bernd, et al.
Publicado: (2021)

Differentially induced immunity in buccal and nasal mucosae after vaccination for SARS–CoV–2: Prospects for mass scale immunity-screening in large populations
por: Tsamadou, Chrysanthi, et al.
Publicado: (2022)

Increased plasma level of soluble P-selectin in non-hospitalized COVID-19 convalescent donors
por: Müller, Rebecca, et al.
Publicado: (2022)

BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages
por: Jahrsdörfer, Bernd, et al.
Publicado: (2022)

One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients
por: Körper, Sixten, et al.
Publicado: (2022)

mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects
por: Fabricius, Dorit, et al.
Publicado: (2021)

Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma
por: Tonn, Torsten, et al.
Publicado: (2020)

No Correlation between Anti-PF4 and Anti–SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination
por: Uzun, Günalp, et al.
Publicado: (2021)

SARS-CoV-2 cross-reactivity in healthy donors
por: van der Heide, Verena
Publicado: (2020)

SARS-CoV-2 vaccines and donor recruitment for FMT
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Authors’ response: SARS-CoV-2 detection by real-time RT-PCR
por: Corman, Victor M, et al.
Publicado: (2020)

SARS-CoV-2-reactive T cells in patients and healthy donors
por: Pia, Luisanna
Publicado: (2020)

Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
por: Steenhuis, Maurice, et al.
Publicado: (2021)

Cadaveric donor specimens and serological testing for SARS-CoV-2
por: Yeang, Malinna, et al.
Publicado: (2022)

Vaccination and SARS-CoV-2 seroprevalence in blood donors: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Transplantation of hearts from SARS‐CoV‐2 positive donors
por: Akhyari, Payam, et al.
Publicado: (2023)

SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History
por: Drews, Steven J., et al.
Publicado: (2022)

Authors’ response: Plenty of coronaviruses but no SARS-CoV-2
por: Reusken, Chantal B, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
por: Ng, Dianna L., et al.
Publicado: (2020)

The prevalence of antibodies to SARS-CoV-2 among blood donors in China
por: Chang, Le, et al.
Publicado: (2021)

Rapid biosensing SARS-CoV-2 antibodies in vaccinated healthy donors
por: Bian, Sumin, et al.
Publicado: (2022)

Tracking SARS-CoV-2 seroprevalence among Canadian blood donors
por: Saeed, Sahar, et al.
Publicado: (2022)

372. Detection of SARS-CoV-2 RNAemia in Deceased Tissue Donors
por: Greenwald, Melissa, et al.
Publicado: (2021)

Anti‐SARS‐CoV‐2 vaccines in recipient and/or donor before allotransplant
por: Jullien, Maxime, et al.
Publicado: (2022)

Kidney transplantation from SARS-CoV-2–positive deceased donor
por: Molnar, Miklos Z., et al.
Publicado: (2022)

The changing profile of SARS-CoV-2 serology in Irish blood donors
por: Coyne, Dermot, et al.
Publicado: (2023)

An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection
por: Conzelmann, Carina, et al.
Publicado: (2020)

Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?
por: Gussarow, Daniel, et al.
Publicado: (2021)

SARS-CoV-2 infection in a stem cell transplant recipient grafted from a SARS-CoV-2-positive donor
por: Busca, Alessandro, et al.
Publicado: (2022)

Correlation between Clinical Characteristics and Antibody Levels in COVID-19 Convalescent Plasma Donor Candidates
por: Uzun, Günalp, et al.
Publicado: (2023)

SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma
por: Dulipsingh, Latha, et al.
Publicado: (2020)

Low awareness of past SARS-CoV-2 infection in healthy plasma donors
por: van den Hurk, Katja, et al.
Publicado: (2021)

Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors
por: Razafimahatratra, Solohery Lalaina, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in 2115 blood donors from Romania
por: Olariu, Tudor Rares, et al.
Publicado: (2021)

Progression and Predictors of SARS-CoV-2 Antibody Seroreactivity In US Blood Donors
por: Vassallo, Ralph R., et al.
Publicado: (2021)

Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors
por: Franchini, Massimo, et al.
Publicado: (2021)

Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil
por: Prete, Carlos A., et al.
Publicado: (2022)

Organ donor with PCR positive for SARS-CoV-2, it has been always no?()
por: Royo-Villanova Reparaz, M., et al.
Publicado: (2022)

Trends and risk factors of SARS‐CoV‐2 infection in asymptomatic blood donors
por: Valenti, Luca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jtdhla79cv6ajlrdbk2c7u8i59